Sage Therapeutics (NASDAQ:SAGE) is preparing to release its quarterly earnings on Tuesday, 2024-10-29. Here’s a brief overview of what investors should keep in mind before the announcement. Analysts expect Sage Therapeutics to report an earnings per share (EPS) of $-1.55. Sage Therapeutics bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter. New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forec…